Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-744 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-744 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
filingDate |
1986-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4990400b60c6107400d3fd1ba9ef9a7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d790c8d87cc6fd371500ee7f7ceae6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea728cc028259e2a28fc35ec44efcc3e |
publicationDate |
1990-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NO-165662-B |
titleOfInvention |
PROCEDURE FOR THE PREPARATION OF A SUCCARIDE DEGREE INHIBITIVE COMPOSITION. |
abstract |
The present invention concerns a saccharide digestion inhibitor comprising a combination of an alpha -glucosidase inhibitor and non-pathogenic lactic acid producing live bacteria and a saccharide digestion inhibiting composition containing both of said components. Oral administration of the saccharide digestion inhibitor or composition to man or animals results in the prevention or treatment of diabetes and obesity without resort to dieting and substantially without inducing side effects such as diarrhea, abdominal distension, etc. which are found with the alpha -glucosidase inhibiting substance administered alone. |
priorityDate |
1985-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |